All In Biotech

Drug Trial Radar · NCT00002110

A Phase II/III Study of Cysteamine (Mercaptoethylamine) and Zidovudine for the Treatment of HIV Disease

Last checked: Nov 19, 2026Latest source record: Jun 24, 2005 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

300

Actual

Start

Not stated

Primary completion

Not stated

Sponsor

Lead sponsor
Mylan LaboratoriesIndustry
Sponsor type
Industry
First posted
Aug 31, 2001

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Masking
Double
Primary purpose
Treatment
Who can join
All sexes, from 13 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

To determine the safety and tolerance of low-dose versus high-dose cysteamine administered concurrently with zidovudine (AZT). To determine the pharmacokinetics and effects on immune function and viral load in patients receiving these drug regimens.

Conditions

  • HIV Infections

Interventions

  • CysteamineDrug

  • ZidovudineDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

No primary outcomes listed.

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Infectious Disease Research Institute Inc

    Tampa, Florida

  • Tulane Univ Med School

    New Orleans, Louisiana

  • SUNY / Health Sciences Ctr at Stony Brook

    Stony Brook, New York

  • Bowman Gray School of Medicine / North Carolina Baptist Hosp

    Winston-Salem, North Carolina

  • Independent Research Nurses Inc

    Cranston, Rhode Island

  • Univ of Texas Southwestern Med Ctr of Dallas

    Dallas, Texas

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.